[
  {
    "ts": null,
    "headline": "Spotlight On Coca-Cola, Ford, AstraZeneca Earnings",
    "summary": "Spotlight On Coca-Cola, Ford, AstraZeneca Earnings",
    "url": "https://finnhub.io/api/news?id=5ca4aec29dc6a9800394b7db9e74698d9736b0b6f57431b318ce59910f27649d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770462000,
      "headline": "Spotlight On Coca-Cola, Ford, AstraZeneca Earnings",
      "id": 138385816,
      "image": "",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5ca4aec29dc6a9800394b7db9e74698d9736b0b6f57431b318ce59910f27649d"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Gilead Sciences (GILD) Valuation After Its Strong Recent Share Price Performance",
    "summary": "Recent performance snapshot Gilead Sciences (GILD) has drawn fresh attention after a strong run in its share price, with the stock up 2.1% over the past day and 7.4% over the past week. Over the past month, the stock has returned 22.6%, contributing to a 28.3% gain in the past 3 months and a 63.2% total return over the past year, based on recent data. See our latest analysis for Gilead Sciences. The recent 1 month share price return of 22.6% and 1 year total shareholder return of 63.2%...",
    "url": "https://finnhub.io/api/news?id=053e269a09196284cfe1cc182a60a479564227c73d08b000efe194bb5c35b8b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770430080,
      "headline": "Assessing Gilead Sciences (GILD) Valuation After Its Strong Recent Share Price Performance",
      "id": 138382263,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Recent performance snapshot Gilead Sciences (GILD) has drawn fresh attention after a strong run in its share price, with the stock up 2.1% over the past day and 7.4% over the past week. Over the past month, the stock has returned 22.6%, contributing to a 28.3% gain in the past 3 months and a 63.2% total return over the past year, based on recent data. See our latest analysis for Gilead Sciences. The recent 1 month share price return of 22.6% and 1 year total shareholder return of 63.2%...",
      "url": "https://finnhub.io/api/news?id=053e269a09196284cfe1cc182a60a479564227c73d08b000efe194bb5c35b8b9"
    }
  }
]